Arica Sargent, PA
Medical · Charlotte, NCNPI 1538219621
Payments from drug & device makers
Across 743 payments — averaging $13.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Biohaven Pharmaceuticals, Inc.$993
- Teva Pharmaceuticals USA, Inc.$836
- Currax Pharmaceuticals LLC$833
- Tonix Medicines, Inc.$795
- Scilex Pharmaceuticals Inc.$655
- plus $4K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 159 | $2,435 |
| Biohaven Pharmaceuticals, Inc. | 74 | $993 |
| Teva Pharmaceuticals USA, Inc. | 52 | $836 |
| Currax Pharmaceuticals LLC | 72 | $833 |
| Tonix Medicines, Inc. | 86 | $795 |
| Scilex Pharmaceuticals Inc. | 66 | $655 |
| Amgen | 35 | $616 |
| Pfizer | 28 | $439 |
| Impel Pharmaceuticals Inc. | 26 | $404 |
| Biohaven Pharmaceutical Holding Company Ltd. | 48 | $385 |
| Lilly USA, LLC | 20 | $382 |
| Lundbeck LLC | 18 | $295 |
| Axsome Therapeutics, Inc. | 10 | $230 |
| Upsher-smith Laboratories LLC | 10 | $214 |
| UCB, Inc. | 8 | $138 |
| Novartis | 5 | $95 |
| Eisai Inc. | 4 | $92 |
| Impel Pharmaceuticals LLC | 4 | $77 |
| Azurity Pharmaceuticals, Inc. | 4 | $77 |
| IBSA Pharma Inc. | 4 | $67 |
| Amneal Pharmaceuticals LLC | 2 | $45 |
| Averitas Pharma Inc. | 2 | $41 |
| Catalyst Pharmaceuticals, Inc. | 1 | $28 |
| Novo Nordisk | 1 | $23 |
| Novocure Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
| GE HealthCare | 1 | $3 |
How this compares
$10,241 in reported general payments places this provider in the 90th percentile of 878 medical providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Charlotte
- Joel ThompsonCharlotte$269K
- Rochelle LunaCharlotte$19K
- Dana DorenfeldCharlotte$17K
- Keri SquittieriCharlotte$17K
- Tonya FraserCharlotte$16K
- Lisa MatugaCharlotte$15K
- Claire HolmquistCharlotte$14K
- Tyler HyslepCharlotte$13K
- Rahele MohseniCharlotte$12K
- Rachelle CroninCharlotte$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.